• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    ARCA biopharma, Inc. (ABIO)

    -NasdaqCM
    3.35 Up 0.01(0.30%) May 27, 3:59PM EDT
    Prev Close:3.34
    Open:3.30
    Bid:3.35 x 5800
    Ask:3.37 x 200
    1y Target Est:16.50
    Beta:0.620152
    Earnings Date:Aug 9 - Aug 15 (Est.)
    Day's Range:3.30 - 3.37
    52wk Range:3.05 - 10.85
    Volume:4,444
    Avg Vol (3m):19,033
    Market Cap:30.37M
    P/E (ttm):N/A
    EPS (ttm):-1.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ABIO

    Comparison

    Symbol% ChgMkt Cap
    ABIOUp 0.30%30.37M
    AZNDown 0.23%75.60B
    GSKDown 0.79%103.84B
    ILIUDown 5.41%24.22M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator, which is in clinical... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback